Flerie AB (publ) (1NP1.F)
Frankfurt · EUR · Healthcare · Biotechnology
€1.22 (+2.10%) as of
Key statistics
- Market cap
- 105.34M
- EPS (TTM)
- -1.0300
- Dividend yield
- 0.00%
- 52-week range
- 1.1900 – 3.1806
- Beta
- -0.33
- Profit margin
- 0.00%
- Volume
- 22.02k
About Flerie AB (publ)
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Stockholm, Sweden
- Employees
- 8
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.